Cargando…

CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer

Objective: To evaluate whether a radiomics signature could improve stratification of postoperative risk and prediction of chemotherapy benefit in stage II colorectal cancer (CRC) patients. Material and Methods: This retrospective study enrolled 299 stage II CRC patients from January 2010 to December...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Shuxuan, Cui, Xiaonan, Liu, Chunli, Li, Xubin, Zheng, Lei, Song, Qian, Qi, Jin, Ma, Wenjuan, Ye, Zhaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017337/ https://www.ncbi.nlm.nih.gov/pubmed/33816297 http://dx.doi.org/10.3389/fonc.2021.644933

Ejemplares similares

Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer
por: Fan, Shuxuan, et al.
Publicado: (2022)

A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
por: Li, Wencui, et al.
Publicado: (2022)

Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma
por: Zhang, Haijie, et al.
Publicado: (2022)

Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
por: Qu, Hui, et al.
Publicado: (2023)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

CT-Based Radiomics Signatures for Predicting the Risk Categorization of Thymic Epithelial Tumors
por: Liu, Jin, et al.
Publicado: (2021)

A radiomics nomogram for predicting postoperative recurrence in esophageal squamous cell carcinoma
por: Tong, Yahan, et al.
Publicado: (2023)

T1 Stage Clear Cell Renal Cell Carcinoma: A CT-Based Radiomics Nomogram to Estimate the Risk of Recurrence and Metastasis
por: Kang, Bing, et al.
Publicado: (2020)

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma
por: Chen, Xin, et al.
Publicado: (2021)

Preoperative radiomic signature based on CT images for noninvasive evaluation of localized nephroblastoma in pediatric patients
por: Ma, Xiao-Hui, et al.
Publicado: (2023)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics
por: Li, Jiaru, et al.
Publicado: (2021)

Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer
por: Li, Junmeng, et al.
Publicado: (2020)

CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades
por: Wu, Wenli, et al.
Publicado: (2019)

CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer
por: Chen, Weitian, et al.
Publicado: (2022)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Prediction value of (18)F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer
por: Liu, Xin, et al.
Publicado: (2022)

Feasibility Study on Predicting Recurrence Risk of Bladder Cancer Based on Radiomics Features of Multiphase CT Images
por: Qian, Jing, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2022)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

Prediction of Pancreatic Neuroendocrine Tumor Grading Risk Based on Quantitative Radiomic Analysis of MR
por: Li, Wei, et al.
Publicado: (2021)

Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm
por: Wang, Leyao, et al.
Publicado: (2022)

A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer
por: Ma, Tingting, et al.
Publicado: (2022)

A CT-based radiomics approach to predict immediate response of radiofrequency ablation in colorectal cancer lung metastases
por: Huang, Haozhe, et al.
Publicado: (2023)

CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study
por: Li, Hailin, et al.
Publicado: (2020)

CT-Based Radiomics Nomogram Improves Risk Stratification and Prediction of Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy
por: Wu, Cuiyun, et al.
Publicado: (2022)

CT-Based Peritumoral and Intratumoral Radiomics as Pretreatment Predictors of Atypical Responses to Immune Checkpoint Inhibitor Across Tumor Types: A Preliminary Multicenter Study
por: He, Shuai, et al.
Publicado: (2021)

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
por: Xiong, Zhi-Zhong, et al.
Publicado: (2023)

The value of machine learning based radiomics model in preoperative detection of perineural invasion in gastric cancer: a two-center study
por: Gao, Xujie, et al.
Publicado: (2023)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023)

CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
por: Song, Bolin, et al.
Publicado: (2023)

Radiomics-based T-staging of hollow organ cancers
por: Huang, Dong, et al.
Publicado: (2023)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_178vm9r2j48e99uslfni3umpqr